Cargando…
NURS-02. CLINICAL MANAGEMENT OF PATIENTS RECEIVING CAR T CELL THERAPY FOR CNS TUMORS
Chimeric antigen receptor (CAR) T cells are an innovative new therapy with proven efficacy in some pediatric cancers such as leukemia and lymphoma, but much less experience in solid tumors, especially tumors of the central nervous system (CNS). Seattle Children’s has three open Phase 1 CAR T cell st...
Autores principales: | Holtzclaw, Susan, Hoeppner, Corrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715868/ http://dx.doi.org/10.1093/neuonc/noaa222.622 |
Ejemplares similares
-
NURS-03. DEVELOPMENT OF A PATIENT-HELD TREATMENT SUMMARY FOR PAEDIATRIC CNS TUMOUR PATIENTS
por: McAndrew, Rachel, et al.
Publicado: (2020) -
NURS-01. INTRACEREBROVENTRICULAR DRUG ADMINISTRATION FOR TREATMENT OF PEDIATRIC BRAIN TUMORS
por: Fitzgerald, Caroline, et al.
Publicado: (2020) -
NURS-04. COMBINATION OF NEURO-ONCOLOGY AND DERMATOLOGY CLINICS IMPROVE THE MANAGEMENT AND KNOWLEDGE OF SKIN-RELATED TOXICITIES WITH MEK AND BRAF TARGETED THERAPY
por: McKeown, Tara, et al.
Publicado: (2020) -
NURS-06. NURSING PROFESSIONALS AND THEIR AID IN RESEARCH BIOBANKING
por: Hancock, Lauren, et al.
Publicado: (2020) -
NURS-07. STAFF EDUCATION THROUGH NURSING AND PHARMACY COLLABORATION
por: Hancock, Lauren, et al.
Publicado: (2020)